This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Modernatx, Inc.. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2023-2024
Title: Paolo Lusso: Innovator in HIV Research
Introduction
Paolo Lusso is a prominent inventor based in Rockville, MD, who has made significant contributions to the field of HIV research. With a total of two patents to his name, Lusso's work focuses on developing innovative methods and compositions for combating HIV infection.
Latest Patents
Lusso's latest patents include groundbreaking advancements in HIV RNA vaccines. These patents provide methods and compositions for inducing a broad neutralizing antibody response to HIV infection in subjects. Additionally, he has developed antibodies and antigen-binding fragments that specifically bind to HIV-1 Env and neutralize the virus. His patents also disclose nucleic acids encoding these antibodies, vectors, and host cells, along with methods for detecting HIV-1 using these antibodies. The use of these antibodies, antigen-binding fragments, nucleic acids, and vectors aims to prevent and treat HIV-1 infections effectively.
Career Highlights
Throughout his career, Lusso has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and ModernaTX, Inc. His work in these institutions has allowed him to contribute to significant advancements in medical research and public health.
Collaborations
Lusso has collaborated with notable colleagues, including Peng Zhang and Elisabeth Narayanan, to further his research and innovations in the field of HIV.
Conclusion
Paolo Lusso's contributions to HIV research through his patents and collaborations highlight his dedication to advancing medical science. His innovative approaches have the potential to make a lasting impact on the prevention and treatment of HIV infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile